首页> 外国专利> MONOCLONAL ANTIBODY SPECIFICALLY BINDING HUMAN AND MONKEY CD38 ANTIGEN, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

MONOCLONAL ANTIBODY SPECIFICALLY BINDING HUMAN AND MONKEY CD38 ANTIGEN, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

机译:特异性结合人和猴CD38抗原的单克隆抗体及其制备方法和应用

摘要

Disclosed in the present invention is a monoclonal antibody that specifically binds human and monkey CD38 antigens or a derivative thereof, comprising antigen complementarity-determining regions CDR1, CDR2 and CDR3 of an antibody light chain variable region are respectively amino acid sequences represented by SEQ ID NO: 3, SEQ ID NO: 4 and SEQ ID NO: 5; antigen complementarity-determining regions CDR1, CDR2 and CDR3 of an antibody heavy chain variable region are respectively amino acid sequences represented by SEQ ID NO: 8, SEQ ID NO: 9 and SEQ ID NO: 10. The antibody or the derivative thereof may be used as a component of a pharmaceutical composition or prepared into a suitable pharmaceutical preparation, and may be administered alone or used in combination with other therapeutic means such as chemotherapy drugs, being used for the treatment of tumors having positive CD38 expression, such as human myeloma and human lymphoma.
机译:在本发明中公开了一种特异性结合人和猴CD38抗原或其衍生物的单克隆抗体,其包含抗体轻链可变区的抗原互补决定区CDR1,CDR2和CDR3分别是SEQ ID NO所示的氨基酸序列。 :3,SEQ ID NO:4和SEQ ID NO:5;抗体重链可变区的抗原互补决定区CDR1,CDR2和CDR3分别是由SEQ ID NO:8,SEQ ID NO:9和SEQ ID NO:10表示的氨基酸序列。抗体或其衍生物可以是用作药物组合物的组分或制备成合适的药物制剂,并且可以单独给药或与其他治疗手段(例如化学疗法药物)联合使用,用于治疗CD38表达阳性的肿瘤(例如人骨髓瘤)和人类淋巴瘤。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号